Lawmaker introduces bill to limit state drug, device inspections

The Hill (2/23, Kasperowicz) "Floor Action" blog reported, "Rep. Brian Bilbray (R-CA) this week introduced legislation that would prevent any state from requiring drug or medical device inspections that are duplicative to inspections already required at the federal level by the US Food and Drug Administration (FDA)." The lawmaker said "his bill, the Science and Technology Regulatory Relief Act, is needed in his state because the California Food and Drug Branch is now running inspections that are mostly similar to FDA inspections, which he said is hurting job creation." The measure (H.R. 4056) "would amend the Food, Drug and Cosmetic Act so that duplicative state-level inspections would be eliminated."